Literature DB >> 25294602

Airway metabolic anomalies in adolescents with bronchopulmonary dysplasia: new insights from the metabolomic approach.

Silvia Carraro1, Giuseppe Giordano1, Paola Pirillo1, Michela Maretti1, Fabiano Reniero2, Paola E Cogo3, Giorgio Perilongo1, Matteo Stocchero4, Eugenio Baraldi5.   

Abstract

OBJECTIVES: To assess a group of adolescents with bronchopulmonary dysplasia (BPD) from a biochemical-metabolic standpoint, applying the metabolomic approach to studying their exhaled breath condensate (EBC). STUDY
DESIGN: Twenty adolescents with BPD (mean age 14.8 years) and 15 healthy controls (mean age 15.2 years) were recruited for EBC collection, exhaled nitric oxide measurement, and spirometry. The EBC samples were analyzed using a metabolomic approach based on mass spectrometry. The obtained spectra were analyzed using multivariate statistical analysis tools.
RESULTS: A reliable Orthogonal Projections to Latent Structures-Discriminant Analysis model showed a clear discrimination between cases of BPD and healthy controls (R(2) = 0.95 and Q(2) = 0.92). The search for putative biomarkers identified an altered complex lipid profile in the adolescents with BPD.
CONCLUSIONS: The metabolomic analysis of EBC distinguishes cases of BPD from healthy individuals, suggesting that the lung of survivors of BPD is characterized by long-term metabolic abnormalities. The search for putative biomarkers indicated a possible role of an altered surfactant composition, which may persist far beyond infancy.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25294602     DOI: 10.1016/j.jpeds.2014.08.049

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

1.  Airway metabolome and chronic lung disease of prematurity.

Authors:  Deepa Rastogi; Judy L Aschner
Journal:  J Pediatr       Date:  2014-10-23       Impact factor: 4.406

2.  Umbilical cord blood metabolomics reveal distinct signatures of dyslipidemia prior to bronchopulmonary dysplasia and pulmonary hypertension.

Authors:  Michael R La Frano; Johannes F Fahrmann; Dmitry Grapov; Theresa L Pedersen; John W Newman; Oliver Fiehn; Mark A Underwood; Karen Mestan; Robin H Steinhorn; Stephen Wedgwood
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-08-16       Impact factor: 5.464

3.  Polymorphisms of fibronectin-1 (rs3796123; rs1968510; rs10202709; rs6725958; and rs35343655) are not associated with bronchopulmonary dysplasia in preterm infants.

Authors:  Katarzyna Kosik; Anna Sowińska; Agnieszka Seremak-Mrozikiewicz; Jasmine A Abu-Amara; Salwan R Al-Saad; Lukasz M Karbowski; Katarzyna Gryczka; Grażyna Kurzawińska; Marta Szymankiewicz-Bręborowicz; Krzysztof Drews; Dawid Szpecht
Journal:  Mol Cell Biochem       Date:  2022-03-01       Impact factor: 3.396

4.  Metabolic analysis of infants with bronchopulmonary dysplasia under early nutrition therapy: An observational cohort study.

Authors:  Li Wang; Wen Hua Zhong; Dan Yang Liu; Hai Qing Shen; Zhen Juan He
Journal:  Exp Biol Med (Maywood)       Date:  2021-12-11

Review 5.  Trajectories of Lung Function in Infants and Children: Setting a Course for Lifelong Lung Health.

Authors:  Brian K Jordan; Cindy T McEvoy
Journal:  Pediatrics       Date:  2020-09-16       Impact factor: 7.124

6.  Salivary Telomere Length and Lung Function in Adolescents Born Very Preterm: A Prospective Multicenter Study.

Authors:  Alice Hadchouel; Laetitia Marchand-Martin; Marie-Laure Franco-Montoya; Laetitia Peaudecerf; Pierre-Yves Ancel; Christophe Delacourt
Journal:  PLoS One       Date:  2015-09-10       Impact factor: 3.240

Review 7.  Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development.

Authors:  Tayyab Shahzad; Sarah Radajewski; Cho-Ming Chao; Saverio Bellusci; Harald Ehrhardt
Journal:  Mol Cell Pediatr       Date:  2016-06-29

8.  Urinary 1H-NMR Metabolomics in the First Week of Life Can Anticipate BPD Diagnosis.

Authors:  Maria Cristina Pintus; Milena Lussu; Angelica Dessì; Roberta Pintus; Antonio Noto; Valentina Masile; Maria Antonietta Marcialis; Melania Puddu; Vassilios Fanos; Luigi Atzori
Journal:  Oxid Med Cell Longev       Date:  2018-06-28       Impact factor: 6.543

9.  Metabolic dysregulation in bronchopulmonary dysplasia: Implications for identification of biomarkers and therapeutic approaches.

Authors:  Li Yue; Xuexin Lu; Phyllis A Dennery; Hongwei Yao
Journal:  Redox Biol       Date:  2021-08-13       Impact factor: 11.799

Review 10.  Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant.

Authors:  Lidys Rivera; Roopa Siddaiah; Christiana Oji-Mmuo; Gabriela R Silveyra; Patricia Silveyra
Journal:  Front Pediatr       Date:  2016-03-31       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.